Table 3.

Cancer-specific profile of survivors meeting neither, aerobic-only, strength-only, or combined exercise guidelines

Variable	Neither (n = 281)	Aerobic (n = 133)	Strength (n = 58)	Combined (n = 134)	p value
Cancer type					.008
Leukemia (n = 186)	96 (52%)	37 (20%)	17 (9%)	36 (19%)
Hodgkin lymphoma (n = 187)	64 (34%)	47 (25%)	21 (11%)	55 (29%)
non-Hodgkin lymphoma (n = 233)	121 (52%)	49 (21%)	20 (9%)	43 (19%)
Time since diagnosis					.11
< 2 years (n = 116)	53 (46%)	19 (16%)	17 (15%)	27 (23%)
2-5 years (n = 304)	137 (45%)	78 (26%)	21 (7%)	68 (22%)
> 5 years (n = 186)	91 (49%)	36 (19%)	20 (11%)	39 (21%)
Radiation					.27
No (n = 399)	196 (49%)	83 (21%)	38 (9%)	82 (21%)
Yes (n = 207)	85 (41%)	50 (24%)	20 (10%)	52 (25%)
Chemotherapy					.64
No (n = 173)	81 (47%)	38 (22%)	20 (12%)	34 (20%)
Yes (n = 433)	200 (46%)	95 (22%)	38 (9%)	100 (23%)
Stem cell/marrow transplant					.35
No (n = 541)	255 (47%)	121 (22%)	50 (9%)	115 (21%)
Yes (n = 65)	26 (40%)	12 (19%)	8 (12%)	19 (29%)
Treatment status					.13
Receiving treatments (n = 193)	99 (51%)	38 (20%)	22 (11%)	34 (18%)
Completed treatments (n = 413)	182 (44%)	95 (23%)	36 (9%)	100 (24%)
Recurrence					.88
No (n = 524)	242 (46%)	113 (22%)	54 (10%)	118 (23%)
Yes (n = 82)	39 (48%)	20 (24%)	7 (9%)	16 (20%)
Current cancer status					.007
Disease free (n = 372)	156 (42%)	88 (24%)	32 (9%)	96 (26%)
Existing disease (n = 234)	125 (53%)	45 (19%)	26 (11%)	38 (16%)
Comorbidities					<.001
None (n = 221)	72 (33%)	56 (25%)	25 (11%)	68 (31%)
One (n = 151)	61 (40%)	42 (28%)	12 (8%)	36 (24%)
Two or more (n = 234)	148 (63%)	35 (15%)	21 (9%)	30 (13%)
Exercise recommendation					.07
No (n = 376)	185 (49%)	86 (23%)	36 (10%)	69 (18%)
Yes (n = 230)	96 (42%)	47 (20%)	22 (10%)	65 (28%)